Glaucoma Surgery Devices Market Growth Analysis | Trends, Drivers and Vendor Forecasts for 2021-2025
Recovery and Growth Insights for 2021-2025

The glaucoma surgery devices market and it is expected to grow by $ 1.40 bn, decelerating at a CAGR of almost 26.41% during the forecast period. The growth trajectory of the market is traced through a detailed analysis of the prevalent market forces, trends, and drivers to enable growth projections and insights. This analytical examination of the market will enable businesses to plan and set the path for future growth prospects.

Rely on our business insights to implement a COVID-19 Recovery Plan: Request for Free Sample Report

Glaucoma Surgery Devices Market: Market Segments and Key Trends

The Glaucoma surgery devices market is segmented by Product (MIGS devices, Laser therapy devices, and Conventional therapy devices) and Geography (North America, Europe, Asia, and ROW). North America led the market with 69% of the market growth set to originate from this region during the forecast period. High cost coupled with lack of reimbursements is one of the challenges that will need to be overcome to drive growth. The research report provides market share projections of each segment along with a detailed analysis of all the factors that are likely to boost growth within specific regions as well as global markets.

Glaucoma Surgery Devices Market: What are the Growth Drivers?

The Increasing prevalence of glaucoma is one of the primary factors driving the growth of the glaucoma surgery devices market. The report provides a detailed study of all the factors that are likely to boost the market. An understanding of the key drivers will enable clients to leverage growth opportunities to their advantage with a view to short-term and long-term business goals.

Glaucoma Surgery Devices Market: Competitive Landscape

The market is fragmented. The research report provides insights into the top market player and their product portfolio along with pipeline analysis of upcoming developments and growth opportunities. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. AbbVie Inc., Carl Zeiss AG, IRIDEX Corp., Johnson and Johnson Inc., Lumenis Ltd., Nova Eye Medical Ltd., Quantel Medical, Santen Pharmaceutical Co. Ltd., and Sight Sciences Inc. are some of the major market participants.

For more insights on this market: Download a Free Sample Report

Glaucoma Surgery Devices Market: Key Highlights of the Report for 2021-2025

• CAGR of the market during the forecast period 2021-2025
• Detailed information on factors that will drive glaucoma surgery devices market growth during the next five years
• Precise estimation of the glaucoma surgery devices market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the glaucoma surgery devices market industry across North America, Europe, Asia, and ROW
• A thorough analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of glaucoma surgery devices market vendors

The report provides insights into the following FAQs:

1. What is the market CAGR?
   The market is decelerate at a CAGR of over 26.41%.
    
2. What is the incremental growth of the market?
   The market is expected to grow by $ 1.40 bn through 2021-2025.
    
3. What is a key factor driving this market?
   Increasing prevalence of glaucoma will drive market growth over the forecast period.
    
4. What are the key regions covered in this market research report?
   North America, Europe, Asia, and ROW are the key regions featured in this research report.
    
5. Which is the leading geographic region for this market:
   69% growth will originate from North America
    
6. Who are the leading market vendors?
   The leading vendors in this market are AbbVie Inc., Carl Zeiss AG, IRIDEX Corp., Johnson and Johnson Inc., Lumenis Ltd., Nova Eye Medical Ltd., Quantel Medical, Santen Pharmaceutical Co. Ltd., and Sight Sciences Inc.
    
7. What are the market segments covered in this report?
   The market is segmented by Product (MIGS devices, Laser therapy devices, and Conventional therapy devices) and Geography (North America, Europe, Asia, and ROW)